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Copyright and licensing of scientific data, internationally, are complex and present legal barriers to data sharing,
integration and reuse, and therefore restrict the most efficient transfer and discovery of scientific knowledge. Much
data are included within scientific journal articles, their published tables, additional files (supplementary material)
and reference lists. However, these data are usually published under licenses which are not appropriate for data.
Creative Commons CC0 is an appropriate and increasingly accepted method for dedicating data to the public
domain, to enable data reuse with the minimum of restrictions. BioMed Central is committed to working towards
implementation of open data-compliant licensing in its publications. Here we detail a protocol for implementing a
combined Creative Commons Attribution license (for copyrightable material) and Creative Commons CC0 waiver
(for data) agreement for content published in peer-reviewed open access journals. We explain the differences
between legal requirements for attribution in copyright, and cultural requirements in scholarship for giving
individuals credit for their work through citation. We argue that publishing data in scientific journals under CC0 will
have numerous benefits for individuals and society, and yet will have minimal implications for authors and minimal
impact on current publishing and research workflows. We provide practical examples and definitions of data types,
such as XML and tabular data, and specific secondary use cases for published data, including text mining,
reproducible research, and open bibliography. We believe this proposed change to the current copyright and
licensing structure in science publishing will help clarify what users – people and machines – of the published
literature can do, legally, with journal articles and make research using the published literature more efficient. We
further believe this model could be adopted across multiple publishers, and invite comment on this article from all
stakeholders in scientific research.Introduction
Much has been written about, and support stated for,
sharing and publishing scientific data, in recognition of
the benefits for the economy [1], scientific discovery [2]
and public health [3]. Maximizing the potential of scien-
tific data sharing for the discovery of new knowledge
involves reducing barriers to data dissemination, reuse,
reproducibility and integration. Licensing, ownership,
copyright and intellectual property present legal obsta-
cles to data integration and reuse, which has led to the
development of, and calls for, licensing standards for
open data; where data are explicitly placed in the public
domain with legal rights of the owners waived [4].* Correspondence: iain.hrynaszkiewicz@biomedcentral.com
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distribution, and reproduction in any mediumBioMed Central has previously stated that the concept
of open data, analogous to its policy on open access to
journals, goes beyond making data freely accessible. Data
should also be free to distribute, copy, re-format, and in-
tegrate into new research, without legal impediments
[5]. This position is consistent with the Panton Princi-
ples, which hold that for society to reap the full benefits
of scientific research the published body of knowledge
must be open – readily available such that it can be eval-
uated, reused, criticized and integrated with other know-
ledge without restrictions [6]. For the remainder of this
article the term ‘open data’ is reserved exclusively for
data available according to these principles.
Unfortunately much data – and other content – freely
available on the web are available under restrictive orBioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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criminalizing secondary users of scientific data. Accord-
ing to evidence submitted to the UK Government’s intel-
lectual property review by the Wellcome Trust, 87 per
cent of the material housed in the full-text scholarly
archive UK PubMed Central is unavailable for legal text
and data mining [7]. A key finding of a more recent re-
port, commissioned by JISC, was a need to overcome
legal restrictions and uncertainties surrounding text
mining of scientific literature [8].
Indeed, as recognition of the value of shared life sci-
ence data has increased, so has recognition of intellec-
tual property and copyright as barriers to progress.
Writing in Nature in 2009, Schofield et al., urged that
“any restrictions on use should be strongly resisted and
we endorse explicit encouragement of open sharing” [9];
and Conway and VanLare in JAMA, in 2010, called for
US health care data to be available without intellectual
property constraints [10]. Waiver of all intellectual prop-
erty rights in research data is central to the achievement
of an “information commons”, advocated by organisa-
tions such as Sage Bionetworks, to enhance the (slow-
ing) pace of drug discovery.
The genomics community has shown leadership in
establishing a framework for an “information commons”,
engrained in the Bermuda Principles, and have estab-
lished built-in temporal latencies to data for knowledge
(when data are released), and rights (when rights
restricting use are removed) [11]. Researchers in this
community typically must release their genetic sequence
data immediately, and within 6–12 months release their
exclusive rights in that data. During this relatively short
embargo researchers have their opportunity to exploit
the data for their discoveries, after which the community
at large can benefit, if they wish, from the new data. A
similar model for data release has since been proposed
for clinical trials, although is probably far from imple-
mentation [12]. A number of factors seem to have led to
a successful culture of sharing in the genomics commu-
nity: a need to collaborate and share to achieve a
major goal (the sequencing of the human genome);
effective mechanisms and infrastructure for sharing
large amounts of data (well-funded genetic sequence
databases); scientific community and funding agency
mandates to share data; and importantly, in the con-
text of this article, successful collaborations with the
publishing community. Journals, their editors and pub-
lishers, supported implementation of the Bermuda
Principles by, for example, requiring accession number
for data deposits as a condition of manuscript submis-
sion or publication.
BioMed Central in its August 2010 open data state-
ment [5] and subsequent cross-publisher Publishing
Open Data Working Group meeting identified that opendata in journal publications could be implemented by
specifying that, from a specific date, any author sub-
mitting to a journal or publisher agrees to dedicate the
data elements of their article and supplementary ma-
terial (in particular, additional data files; also known as
“supplementary” data files) to the public domain [13].
Much of the contents of academic journals could be
considered as data but licensing terms cannot be ap-
plied retroactively by publishers without authors’ con-
sent, and any changes to authors’ agreements should
ideally be made in consultation between authors and
publishers.
This article aims to describe practically what is needed
from publishers to explicitly dedicate data within open
access journals to the public domain, and discusses the
implications of this development for authors, editors,
publishers and funders of research. Illustrative examples
and use cases are provided throughout the article. In this
article “open access” is defined according to the Buda-
pest Open Access Initiative definition [14].
Applying the right license to published research
and data
The internet has revolutionized the way we access and
distribute information, enabling virtually anyone to post
content online. There is much potential in rapidly shar-
ing content on the web, but releasing content without
information, or with ambiguous information, about if
and how it can be shared and reused can also cause pro-
blems – especially for data.
Open access publishing of peer-reviewed journal articles
commonly utilizes the legal tools – licenses – prepared by
Creative Commons. BioMed Central, Public Library of Sci-
ence, Nature Publishing Group, BMJ and many others pub-
lish open access articles where the authors retain the
copyright to their work. Authors typically apply a Creative
Commons attribution license (CC-BY), or variation of it,
which means anyone is free to copy, reuse, distribute and
make derivatives from their article provided that there is at-
tribution of the original author(s). However, many “open
access” publishers place restrictions on commercial reuse of
published articles (papers) and on creation of derivative
works, which can include text mining in some jurisdictions.
Additionally, some commercial publishers’ terms and con-
ditions, by contract, can prevent text mining in any jurisdic-
tion. Commercial use restrictions have been strongly
discouraged – their use described as amounting to “pseudo
open access” – as authors will not reap the full benefits of
paying for open access publication (for example figures
could not be uploaded to Wikipedia with commercial use
restrictions) [15,16]. BioMed Central supports unrestricted
use of open access content including commercial use and
as such requires authors to apply a CC-BY license by
default. BioMed Central’s full text corpus of open access
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distribution, reuse and creation of derivatives with no com-
mercial use restrictions – with data mining research
strongly encouraged [17]. For data published by scholarly
publishers, the Association of Learned and Professional So-
ciety Publishers and International Association of Scientific,
Technical, & Medical Publishers (STM) issued a joint state-
ment in 2006 supporting sharing of raw datasets among
scholars and recommending that publishers do not require
transfer of copyright in data submitted for publication
[18].
Copyright and data
The policies and guidelines of many academic institu-
tions advise researchers to establish intellectual prop-
erty and copyrights at the start of any project
(although whether the issue of data ownership is con-
sistently addressed by researchers is unclear [19]).
Copyright cannot generally be asserted in facts, only
the ways in which they are presented. At a basic level
raw data are merely simple, mathematical, descriptions
of facts and to claim copyright a scientist would need
to exert individual judgment, expression or skill in
their representation. For example, Einstein could not
claim copyright in the formula E =mc2, but could in
text explaining the theory behind it [20]. You could
conclude from this that copyright and associated
licenses and attribution requirements cannot legally be
applied to data. However, there are many levels at
which data – particularly digital data derived and inte-
grated from different sources – and collections of data
and metadata can operate and be represented, and
many ways in which copyright law is applied in differ-
ent jurisdictions.
In the US the law focuses on creativity (“Copyright
does not protect facts, ideas, systems, or methods of op-
eration, although it may protect the way these things are
expressed”) but in Australia originality is more import-
ant – and copyright may well apply to research data “in
the same way that it applies to written works like books,
journal articles and reports” [21]. In the European Union
“sui generis” rights exist to protect data within digital
databases – effectively, copyright – which can, further-
more, be implemented differently by member states. Be-
cause of these substantial international legal differences
regarding how copyright can be applied to data, there
are inherent difficulties in ascertaining the extent of
copyright in a dataset. A more comprehensive summary
of the different approaches to copyright in data and
databases can be found in [22]. All of these issues com-
pound the uncertainty about what an individual or ma-
chine (such as a computer crawling the web) can do,
legally, with information they download from the inter-
net, including from journals.Licenses and waivers for data
A license is a legal instrument for a copyright holder or
content producer to enable a second party to use their
content, and apply certain conditions and restrictions to
those uses. A waiver is also a legal instrument but is
designed for a rights holder to give up their rights, rather
than assert them. For a comprehensive guide to the dif-
ferent approaches to the licensing of research data see
[23].
Placing restrictions on the reuse of scientific informa-
tion, particularly data, slows down the pace of research.
Furthermore, legal requirements for attribution
ingrained in licenses such as CC-BY can prohibit future
research across large collections of content – as com-
monly happens in data mining research. Consider the
Human Genome Project: a watershed moment for scien-
tific data sharing and collaboration. Without the collect-
ive effort of many different research institutions,
commercial organizations and individual scientists the
sequencing of the human genome would not have been
possible. But if a researcher wishing to query the human
genome database as part of a new research project was
legally required to attribute all the – probably thousands –
of data contributors, by providing a link back to or citation,
this would be unmanageable, and probably un-publishable
in the context of a traditional research paper’s reference
list.
International legal differences, described earlier, are
another important reason to apply specific, appropriate
legal tools to data. Also, it can be unclear what license
to attach to copyright in a dataset or structure (for ex-
ample a textual description of building the dataset could
fall under CC-BY, but if source code were used rather
than text it might not). This is an area of confusion
where no licensing standard exists. Therefore, to elimin-
ate legal impediments to integration and re-use of data,
such as this stacking of attribution requirements in large
collections of data, and to help enable long-term inter-
operability an appropriate license or waiver specific to
data should be applied. There are a number of confor-
mant licenses and waivers for open data [24], of which
Creative Commons CC0 (http://creativecommons.org/
publicdomain/zero/1.0/) is widely recognized. Under
CC0, authors waive all of their rights to the work world-
wide under copyright law and all related or neighboring
legal rights they have in the work, to the extent allow-
able by law. Legal experts have recommended the use of
standard, globally accepted licenses for data instead of
developing ad hoc models [25].
The case for CC0 for scientific data
The Creative Commons’ website catalogues a number of
different organizations – publicly and privately funded –
which use CC0 for data [26]. These include:
Hrynaszkiewicz and Cockerill BMC Research Notes 2012, 5:494 Page 4 of 12
http://www.biomedcentral.com/1756-0500/5/494 Genomes Unzipped, which “aims to inform the
public about genetics via the independent analysis of
open genetic data, volunteered by a core group of
genetics researchers and specialists”
 GlaxoSmithKline (GSK), a leading pharmaceutical
company, has dedicated data on more than 13,500
compounds known to be active against malaria to
the public domain [27].
 The British Library and Cologne-based Libraries,
which have released large amounts of bibliographic
data under CC0 [28]
 FigShare (http://figshare.com/), a freely-accessible
repository for scientific content including images,
video and data, uses CC0 for datasets
Data repositories are particularly relevant users of
waivers and licenses for research data. Although there
are many data repositories in life sciences (for a list see
http://www.datacite.org/repolist), which are growing in
size and number, not all scientific domains have a
common repository and journals often function as re-
positories when data are included as additional files
(supplementary material). Dryad (http://datadryad.org/)
is an international repository for the datasets supporting
published, peer-reviewed journal articles across the bios-
ciences which requires authors to explicitly place depos-
ited data in the public domain using the CC0 waiver. An
entry on the Dryad weblog sets out cogently why CC0 is
the most effective solution for achieving its goals:
“By removing unenforceable legal barriers, CC0 facili-
tates the discovery, re-use, and citation of [that] data. . .
“Furthermore, Dryad’s use of CC0 to make the terms of
reuse explicit has some important advantages:
 interoperability: Since CC0 is both human and
machine-readable, other people and indexing services
will automatically be able to determine the terms of
use.
 universality: CC0 is a single mechanism that is both
global and universal, covering all data and all
countries. It is also widely recognized.
 simplicity: there is no need for humans to make, and
respond to, individual data requests, and no need for
click-through agreements. This allows more scientists
to spend their time doing science.” [29]
Dryad’s policy ultimately follows the Science Commons’
recommendations, set out in their Protocol for Implement-
ing Open Access Data [30].
The online laboratory notebook software LabArchives
(http://www.labarchives.com/), which includes the ability
to share data privately and to publish datasets publicly and
permanently online, also uses CC0 for public datasets [31].Concerns about public domain dedication of data
Credit where credit’s due – attribution and citation
A common concern about moving from an attribution
license, such as CC-BY, to CC0 for data and waiving at-
tribution rights is that academic credit (citations) will be
lost if there is no longer a legal requirement to attribute
the original rights holder (author). While attribution can
sometimes be achieved in the same way as citation the
two practices serve different purposes. Attribution is a
legal tool designed to permit copying, distribution, and
creation of derivative works such as translations. As
copyright does not protect ideas (in the US), to give
scientists credit for their ideas the established norm in
scholarly communication is citation [32].
Consider a scientist paraphrasing a concept put for-
ward in a peer’s research article. He or she does not le-
gally have to cite their peer’s published paper, but it is
beneficial or possibly essential for the validity and reli-
ability of the subsequent work to specify the source(s) of
assertions made. Community norms are enforced by the
community, and in science unacceptable citation prac-
tices are typically identified and resolved through peer
review, and the publication ethics and editorial policies
of peer-reviewed journals. See Table 1 for common cit-
ation and attribution events in scholarly communication.
These examples are for illustrative purposes and do not
constitute legal advice.
The examples in Table 1 demonstrate that, although
they can sometimes be achieved in the same way, attri-
bution and citation are not the same. Citations are much
more important and relevant than attribution when
tracking scholarly outputs and giving appropriate credit
for individuals’ contributions.
Compared to legal requirements, cultural norms bene-
fit from flexibility, and can evolve with the community
which established them. In other words, using norms
retains control and decision making within the research
community, instead of taking it out of our control and
handing it to lawyers and judges. Many scientific ideas,
after a number of years, become undisputed and the
community may deem it unnecessary for credit to be
rigorously applied. For example, it would today be very
unusual for an article describing a DNA sequencing ex-
periment to cite the original work by Watson and Crick
that elicited DNA’s structural properties. This is a cul-
tural norm at work, where an idea is now so widely
accepted, and the initial authors clearly recognized for
their discoveries (in citations and prizes) a citation is not
needed.
Jonathan Rees, formerly of the Creative Commons, said
of community norms for influencing behavior over legal
requirements: “For widest latitude of use and best scalabil-
ity, and therefore greatest return to the research community,
the entirety of the data set, including any incidental





Printing an article for display at a
conference
Attribution Printing an article is redistribution so covered by copyright (and attribution
is achieved inherently by the authors’ names and copyright ownership
being stated on the article)
Translating article for publication
in another journal
Attribution + citation Attribution is required as a translation is a derivative work, and most
journal duplicate publication policies (an ethical requirement) require
citation of the original paper for republications
Paraphrasing a concept or finding
within a paper
Citation If you rely on another scientists idea for your work credit is due to the
previous author through citation
Reusing a figure, table or graph Attribution + citation Reusing a figure, table or graph is copying and redistribution, so requires
attribution; by presenting another scientist’s representation of their
data you need to give credit to their original work
Publication of a reanalysis of data
published as an additional file in a journal
Citation The source of the data being reanalyzed may not legally need to be attributed
if copyright does not apply (e.g. in the US), even if the data are included with
the secondary publication, but for the reanalysis to stand up to scrutiny – and
pass peer review – the source of the data must be cited
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domain. Note that public domain is not incompatible with
a request for attribution or other terms of use following
community norms. Such a request may be as effective – or
more effective – at getting users to follow desired practices
as any attempted legal restrictions [33].”
To our knowledge there have been no empirical stud-
ies of the citation of scholarly datasets assigned public
domain dedication licenses compared to a comparable
group available under attribution licenses. However,
given public domain dedication – and specifically CC0 –
is intended to maximize the potential for data discovery,
reuse and therefore citation, it would be reasonable to
hypothesize that citation potential of public domain data
would be unaffected or might even increase. With CC0
there is no need for transfer agreements and precondi-
tions, which inherently impede further (re)uses of data.
Sharing of microarray experimental research data under-
lying journal articles has been associated with increased
citation share [34], and increased reproducibility and re-
peatability of results [35]. In social science data collec-
tions funded by the National Institutes of Health and
National Science Foundation in the US, data sharing
has been associated with “many more times the pub-
lications” than collections where data were not
shared [36]. Linking of publications to supporting
datasets has also been associated with more citations
to the linked paper in the marine science journal
Paleoceanography, according to a conference abstract,
and in the field of astronomy according to a pre-
print paper [37].
Competition
Researchers who apply CC0 to their data, or any other
product of their scholarship, waive all rights in that data
allowable by law. Such a waiver has been described as an“unattractive option for data whose creators have yet to
fully exploit them, academically or commercially” [23].
This is true, but a waiver or license required by a journal
or publisher generally applies only in the context of data
submitted for publication. If a portion of a large data-
base was analyzed and an additional data file included
for publication the larger, unpublished, body of work
would retain whichever license the researchers, their
employers or institutions require. In other words,
researchers remain in control of what they chose to pub-
lish – what they submit to a journal – and a change in
the publishers’ license does not affect this. Moreover,
waivers and licenses for journal articles do not replace
existing, established community norms for sharing of
some data types (e.g. depositing microarray and genetic
sequence data in appropriate databases) – nor do they
affect requirements of many journals for sharing readily
reproducible materials including raw data on request
[38].
There is a trade-off between the additional oppor-
tunities which may result from transparency (such as
new collaborations, secondary use) and the threat,
improbable or otherwise, that opening up data may
be valuable to competitors. Certain types of research,
such as genetic sequencing to elucidate susceptibility
to disease, generates far more data than one research
team could conceivably analyze – which logically lead
to sharing and collaboration. A number of companies
have opened up some of their data and seen benefits
[39]. A lot of data may have commercial value but
much raw data, such as protein sequences of poten-
tial drug targets, are just the beginning of a
knowledge-discovery process. More can be gained by
“pre-competitive” sharing with the waiver of intellec-
tual property. Such an approach is being championed
by Sage Bionetworks in the US [40].
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Plagiarism is research misconduct and an unfortunate
but ineliminable occurrence in scholarship. Plagiarism
and the potential for plagiarism have increased with the
proliferation of digital access to information [41]. Pla-
giarism is often not illegal, but it is certainly unethical,
and undoubtedly damaging for the career of someone
guilty of perpetrating plagiarism. Effective online tools
for detecting plagiarism exist, such as CrossCheck
(http://www.crossref.org/crosscheck/index.html), as does
human detection via the peer-review process. Removal
of a legal requirement for attribution for data elements
of articles would be unlikely to impact on the potential
for plagiarism. In addition, CC0 would not apply to the
main, copyrightable text of articles.
Other safeguards
Public domain dedication of data does not mean that
those who generated the data cannot express certain
wishes about how the data are used. The Panton Princi-
ples frequently asked questions (FAQs) state: “You
should always aim to follow any reasonable requests
made by the data owners/publishers. These may be expli-
cit or may be implicitly understood by the community.
You should make an effort to understand any relevant
‘community norms’ for the data you are using [42].”
A code of conduct has been proposed for those
wishing to reuse clinical trial data obtained from other
researchers [43] and a clinical trial dataset published in
the journal Trials, by Sandercock et al., has requested
that “any publications arising from the use of this data-
set acknowledges the source of the dataset, its funding
and the collaborative group that collected the data.”
[44].
Electronic publishing platforms provide further safe-
guards to ownership and authorship of published content,
in the form of date stamping manuscript submissions and
version control in some repositories, such as Edinburgh
DataShare (http://datashare.is.ed.ac.uk/).
Citation of articles and datasets is facilitated through
standard citation formats – such as those advocated by
DataCite where persistent dataset identifiers, such as
digital object identifier (DOI) names, are displayed as
linkable, permanent URLs – and are increasingly sup-
ported by some publishers [37].
What do we mean by data?
There are numerous definitions of data. According to
Wikipedia data “are qualitative or quantitative attributes
of a variable or set of variables. Data are typically the
results of measurements and can be the basis of graphs,
images, or observations of a set of variables,” [45]. Data
can exist electronically or non-electronically, so a defin-
ition that includes electronic access is important, in thecontext of integration, reuse and data mining of online
scholarly content. The Copyright, Designs and Patents
Act, part of UK statute, uses a broad definition of data-
bases incorporating electronic access:
“Databases(1)In this Part “database” means a collection
of independent works, data or other materials which—
(a)are arranged in a systematic or methodical way, and
(b)are individually accessible by electronic or other
means.
(2)For the purposes of this Part a literary work
consisting of a database is original if, and only if, by
reason of the selection or arrangement of the contents of
the database the database constitutes the author’s own
intellectual creation.”
Other definitions, such as at the United States National
Science Foundation ‘DataNet’ program, have been broader
and implied anything capable of existing digitally, including
publications and software, could be considered data [46].
The former definition is more broadly applicable to data
which can be harvested, mined or downloaded from open
access journals – and to which CC0 rather than CC-BY
should apply. This inevitably means information which can
be processed by machines as well as being transferred elec-
tronically by them (e.g. papers attached to emails) [47]. It is
not possible to comprehensively define and account for all
data and data file types, particularly given the rapidly evolv-
ing nature of data and text mining applications, but a num-
ber of general examples and definitions follow below. We
strongly encourage readers to comment on these data defi-
nitions and provide additions and amendments. These
examples intentionally do not include domain-specific data
standards (agreed upon formats for disseminating and pre-
senting particular types of scientific experiments), which
are comprehensively catalogued by BioSharing (http://
biosharing.org/?q=standards).
Tabular data
Data elements organized in columns and rows – a table –
are extremely common in scientific publications. While at-
tribution would be required for reproduction in whole or
in part of a table as presented in a journal publication, the
individual values and collection of values should be consid-
ered as data and therefore open. Data, in the course of a
scientific experiment, are usually collected at a greater level
of detail than are reported in a paper, with tables reporting
summary or mean values. Although these data are aggre-
gated from the raw data they remain numerical representa-
tions of a fact, and therefore data. Tables are furthermore
often included as additional files in a variety of formats in-
cluding PDF, HTML/XML, DOC and Excel/CSV. Ideally
all tables included in the main body of a journal article
should also be included as additional CSV files – an open,
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as tables in journal articles CSV would represent good
practice for tabular data. Proprietary file types, such as
Microsoft Office, and formats which are not readily edit-
able, such as PDF, are not recommended for tabular data
provided as additional data files.
Graphs and graphical points
Graphs, graphical representations of relationships be-
tween variables, are ostensibly images and therefore not,
when considered as a collective entity, data. However,
the individual data points underlying a graph, similar to
tables, certainly are. An example of best practice when
submitting a manuscript with a graph to a peer-reviewed
journal would be for authors to also submit accompany-
ing CSV tables with the corresponding data points, so
that graphs could be re-plotted. Although this practice is
required by some specific journals it is not widespread.
However, software tools exist that are capable of “scrap-
ing” underlying data points from graphs and images (for
example http://www.chardta.com/) and can be useful,
for example, for enhancing the discoverability of scien-
tific information by exposing underlying data points to
internet search engines.
XML
According to the World Wide Web Consortium (W3C),
“Extensible Markup Language, abbreviated XML,
describes a class of data objects called XML documents
and partially describes the behavior of computer pro-
grams which process them” [48]. XML is widely used as
a standard for data transfer and for creating versions of
works intended for machine reading, and therefore to be
used as data. Therefore for our purposes we can assume
XML files are data. XML has many applications in sci-
ence and is frequently published with journal articles as
additional files in BioMed Central journals as well as
underlying the online articles themselves. XML forms
the basis of many domain-specific data standards such
as Gating-ML in flow cytometry, FuGE-ML in functional
genomics, GelML in gel electrophoresis and so on (see:
http://biosharing.org/standards_view).
Bibliographic data
Bibliographic data have been historically described as infor-
mation not included in the full text and images included
with an article, which includes reference lists. “Core biblio-
graphic data” have been further described as “data which is
necessary to identify and / or discover a publication” and
defined under the Open Bibliography Principles:
 names and identifiers of author(s) and editor(s)
 titles
 publisher information publication date and place
 identification of parent work (e.g. a journal)
 page information
 Uniform resource identifiers (URIs) [49]
Therefore, these core bibliographic data should be
considered open data.
RDF
Resource Description Framework (RDF) is a standard
language for encoding data and metadata on the web. It
is designed to indicate the relationship between online
objects in a human and machine-readable way, and fa-
cilitate merging of data between different sources even if
the underlying schemas of the sources are different. RDF
forms the basis of the semantic web, and is a core com-
ponent of achieving Tim Berners-Lee’s vision of Linked
Data on the web [50]. RDF provides new opportunities
for data and knowledge management in life sciences,
chemistry, and publishing. All BioMed Central journal
articles, for example, contain embedded RDF, which
conveys harvestable information about content, such as
authors, licensing information and the unique identifier
for the article [51].
What aren’t data?
Although source code may be represented as data and is
certainly machine readable there are a wide range of
existing licensing systems and community norms that
exist around software. Therefore we choose to regard
software, compiled code, and source code as a separate
category and not as data. Specific licenses and repositor-
ies have been developed for source code for software
and Open Source Initiative compliant licenses [52] are
recommended. Files pertaining to programming lan-
guages can be included as additional files with journal
publications, either directly in formats such as SQL or
indirectly in compressed or packaged file formats such
as ZIP.
There are myriad file types which can be published as
additional files but amongst the most common, in BioMed
Central journals, are those usually pertaining to text and
written works – PDF and DOC/DOCX and HTML (a full
list of published additional data files is available on request
from BioMed Central [53]). Caution is recommended in
the interpretation of these objects as open data.
Implementing a variable license for open access
research and data
Setting date (CC) Zero
Creative Commons licenses (CC-BY, specifically) have
provided an effective and penetrative solution for digital
copyright in open access scientific works (papers). But as
the nature of the published scientific paper (article) has
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structure which authors apply to their content. Pub-
lished articles are increasingly collections of different
digital objects, perhaps including a few thousand words
of text, half a dozen images and a similar number of
CSV or XML (data) files.
The fact that CC-BY is a suboptimal license for data does
not mean that the many thousands of published authors
have done something wrong, as CC-BY was (and often still
is) the best instrument available when copyright license
agreements for open access journals were prepared (al-
though, CC-BY version 4.0, currently in draft form, aims to
tackle the issue of sui generis database rights [54], described
earlier). A number of data repositories, including Dryad
and FigShare, initially asked authors to make their depos-
ited data available under a Creative Commons attribution
license but have since changed their policy (https://twitter.
com/#!/figshare/statuses/50241486796754944). However, li-
censes and waivers cannot be applied retroactively by a
publisher without explicit consent of the copyright holder
(s) – in the vast majority of cases at BioMed Central, the
authors. A small number of datasets remain in Dryad which
are not available under CC0, as explicit agreement from
data depositors (rights holders) could not be obtained to
change the terms of data release [29].
A change to BioMed Central’s standard license agree-
ment to include a CC0 waiver for published data would
remove ambiguities about the copyright and attribution
requirement status of parts of published articles and
associated data files, and enable instead the application
of scientific, cultural norms that meet the needs of scien-
tists better than an inflexible legal instrument [33,55]. To
implement open data in journal publications the new
license agreement would need apply to all authors from a
specific date, such that any author submitting to a jour-
nal/publisher agrees to dedicate the data elements of
their article and additional files to the public domain. A
proposal for how this could be reflected in published
articles’ copyright license statement follows:
“© 2012 <Author> et al. This is an Open Access article
distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited. Data
included in this article, its reference list(s) and its additional files,




This would be further indicated in article metadata, RDF
and on the journal and publisher’s policy pages and author
submission pages online. This addition to the statementaims to succinctly summarize that data in published arti-
cles generally originates from three sources – tabular data
or text-minable factual data (e.g. numerical instances of a
particular word or phrase, such as gene/protein names) in
the main body of an article; additional (supplementary)
files such as XML and CSV file extensions that include
data; and the reference list (bibliographic data). From a
legal perspective, we might need to be more comprehen-
sive about our definitions of data (see ‘What do we mean
by data?’, above) in the full legal code of a new license and
in guidelines accompanying this proposed change. And
practically, authors would need to agree to apply two dif-
ferent legal tools to content they submit for publication as
part of the submission process – with links to both CC-BY
and CC0, for example, in journal submission checklists.
The need for change in author behavior, as a result of
this proposed modification, is minimal. CC0 would not
apply to nor affect the availability of data not submitted
for publication; we would instead be asking authors to
apply different terms of use to a proportion of the con-
tent they already publish. By submitting a manuscript
and all associated files to a BioMed Central journal
authors already confirm that they agree to all terms of
the BioMed Central Copyright and License Agreement
[56], including that they are able to apply a CC-BY li-
cense. This proposed change to the license agreement
should provide clarity to the licensing of specific compo-
nents of published articles and does not represent a sub-
stantial change to the overall license agreement for
authors’ published work.
Open data by default – opt out
Public domain dedication of data, while universally de-
sirable, is not always universally possible. Authors, for
the most part, prepare research articles in the context of
employment by a third party and can be subject to li-
censing terms which supersede the standard terms of a
publisher. This already happens for a small proportion
of the content published by BioMed Central and un-
doubtedly by other publishers, such as some articles
funded by the World Health Organization and US gov-
ernment. Therefore, any submitting author who is not
able to agree to all terms of the BioMed Central Copy-
right and License Agreement should contact the journal
editorial office at the earliest opportunity – ideally be-
fore, during or immediately after manuscript submission.
The onus is on the authors and, if applicable, their
employers to decide on the applicability of the publisher’s
standard license agreement to their work and whether an
exception is needed. Alternatives to the standard license
agreement can be discussed. This process of checking suit-
ability of the standard license agreement, and requesting
alternatives where necessary, therefore already happens
for all manuscripts submissions. The owners of the rights
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open. According to the Panton Principles FAQs “[i]n most
cases, the people who make a decision to publish, and
were intimately involved in the generation of the data,
should be making this decision.” [42]Publishing platform developments
Implementing a new license agreement will have tech-
nical as well as policy and procedural implications.
While it is not possible to specify these changes in detail
here, and is beyond the scope of this document, the fol-
lowing would be essential for implementation:
 Tagging of articles and data files published under a
non-standard license agreement (where authors have
opted out of the new default open access-open data
license)
 Editing standard embedded license information in
article XML metadata and RDF and a tool to
automate insertion of non-standard licensing terms
 Insertion of license information to additional files
and associated metadata
Furthermore, the following would be desirable to en-
hance the discoverability and usefulness of open data in
journal articles:
 Tagging and classification of published data files, for
example by file type
 A tool to automatically discover and aggregate
additional files
 A tool to (retrospectively) associate data objects
with papers on the web
 Approaches to associating published datasets with
journal articles which go beyond hyper-linking, such
as through linked data methods
 Searching within and filtering of additional filesOpen data in science use cases in published and
unpublished contexts
There are many uses for open data but probably many
more as yet unknown. As stated by Tim Berners-Lee
and Nigel Shadbolt in The Times on New Year’s Eve
2011, “One reason that the worldwide web worked was
because people reused each other’s content in ways never
imagined or achieved by those who created it. The same
will be true of open data.”
The examples that follow focus on licensing and reuse
of data included with and/or harvestable from journal
publications, in the context of the proposed change to
BioMed Central’s standard license agreement, above, for
open access and open data journal articles.Example #1 – analysis of a large clinical trial dataset
In April 2011 Sandercock et al., published in Trials ‘The
International Stroke Trial Database’ [44], which “aimed
to make individual patient data from the International
Stroke Trial (IST), one of the largest randomised trials
ever conducted in acute stroke, available for public use,
to facilitate the planning of future trials and to permit
additional secondary analyses.”
The “database”, including 19,000 anonymized individual
patient data, is available with the journal article as a
4.3 Mb CSV file (http://www.trialsjournal.com/content/
supplementary/1745-6215-12-101-s1.csv) under a CC-BY
license. With the new license agreement as proposed in
this article the CSV file would be available for reuse with-
out a legal requirement for attribution engrained in CC-
BY. Secondary uses for this dataset might include a novel
secondary analysis by a different group of researchers, and
analysis and integration of the dataset in the context of a
systematic review and meta-analysis of randomized trials
of heparin and/or aspirin in acute ischemic stroke. Both of
these activities might conceivably result in further publica-
tions. Although there would be no legal requirement for at-
tribution, for any secondary article about this dataset – or
indeed any systematic review – to be scientifically valid it
would need to cite its source(s) of data.
Example #2 – Application of magnetic resonance
techniques to cross-species comparative studies
Magnetic Resonance Imaging (MRI) techniques are used to
better understand the evolution of specific traits in animals
and cross-species comparisons (for example in primates)
are particularly important. But due to ethical, practical and
funding limitations single studies typically are only able to
consider one or two species. There is only one publicly
available dataset that has brains from multiple primate spe-
cies scanned according to a common protocol and these
scans (of 11 species) were recorded (in vivo) well over a
decade ago, and so do not meet the quality criteria that
underpin more recent brain morphometric algorithms of
the kind required for cross-species studies of brain struc-
ture. However, a review of this area of research found that
“the major barrier to cross-species MR-based brain morph-
ometry is not the lack of data nor analytical tools but bar-
riers preventing to combine them” [57]. Open data in this
field would undoubtedly drive new discoveries.
Example #3 – Research utilizing text and data from
journal publications
The copyright status of data obtained though text-mining
is debatable. The numerical instances of a particular gene
or protein name in a full-text corpus of articles could be
valuable for secondary research and, in the US at least, are
likely to be considered (non-copyrightable) facts. Some
scholars take the position that mining does not violate
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ition of copying which requires “fixing” the work in a per-
manent form [15]. Yet text mining is often restricted by
commercial publishers. In the study of small angle scatter-
ing (a “technique based on the deflection of a beam of par-
ticles, or an electromagnetic or acoustic wave, away from
the straight trajectory after it interacts with structures that
are much larger than the wavelength of the radiation”
according to Wikipedia [58]), a researcher might be inter-
ested to harvest the data used in other publications to test
their analysis tools and provide better teaching aids. Gener-
ally, in this area of research, the data are only presented as
a graph, the data analysis is not spelt out and there is no
specific license attached if the data are available (Cameron
Neylon, personal communication).
Example #4 – Open bibliography
Online scientific publishing has driven a diversification of
measures of research and researcher impact, extending
the focus from journal impact factors to article and
individually-led metrics. Bibliographic information (rather
than copyright attribution), which enables identification of
scholarly work and tracks citations to scientists’ work, is
central to earning of academic credit for concepts and
ideas. Many services are now available which enable indi-
vidual authors to calculate their citation index, known as
the Hirsch or h-index. Examples include Scopus, Thomson
ISI, Google Scholar and Microsoft Academic Search. How-
ever, much of the data underlying these metrics is not avail-
able openly, leading to multiple scores for the same
individual or paper – depending on the tool or service used,
which have different corpuses and different algorithms for
calculating impact scores. A common, open bibliography,
as has been established by some leading libraries would en-
able anyone to assess, utilize and build applications based
on the data [59]. And furthermore, from a researcher’s per-
spective this approach is far more efficient, negating the
need to maintain and report multiple sources of data from
multiple impact-measuring tools. As outlined by Jones
et al. [49] the motivations for and opportunities for open
bibliographies are many. The negative implications of open
bibliography for an author of a paper are negligible. Under
the license agreement proposed in this article CC0 would
apply to the article title, author names and information,
unique identifying and publishers’ information, and refer-
ence list. Given a primary use of bibliographic information
is to track scholarly citation activity, authors could reason-
ably expect these open data to increase the visibility and
impact of their work.
Example #5 – Reproduction/validation of results for
teaching and further research
In September 2010 Tommi Nyman and colleagues pub-
lished an article in BMC Evolutionary Biology, “Howcommon is ecological speciation in plant-feeding insects?
A 'Higher' Nematinae perspective” [60]. The article
included, in addition to the sequence data used to recon-
struct the phylogenetic trees, the background data used in
the phylogeny-based ecological analyses as additional file
1 – an Excel file. The data are well labeled and readily
understandable by other scientists and fully document
how they sampled their insects. This informative approach
means, for example, readers would not need work through
the references to discover the sampling used. These data
have potential usage for reproduction and validation of
the article’s findings, for teaching purposes, and conceiv-
ably uses involving the processing and integration of the
data using computer software. Explicit dedication of these
data to the public domain minimizes barriers to these sci-
entifically important activities and maximizes the reuse
potential of the data, as we could be more confident that
all future uses of the data will not be impeded by licensing
restrictions.
Concluding remarks – and what next?
Legal issues present substantial barriers, in theory and
reality, to the reuse and integration of research data which
are free to access online, and data published in peer-
reviewed journals. The implementation of a new license
and waiver agreement, as per the protocol described in
this article, in BioMed Central journals and in the future
by other open access publishers should help further realize
the benefits of open data for the scientific community –
and beyond. We invite all our readers and authors to con-
sider and comment on the implications of the proposed
change to BioMed Central’s license agreement set out in
this article.
Competing interests
MC is Managing Director of BioMed Central, part of Springer Science +
Business Media. IH is an employee of BioMed Central.
Authors' contributions
The idea for this manuscript was conceived at a meeting (reported on the
BioMed Central Blog, [13]) which was attended by MC and a number of
those listed in the acknowledgements section of this article. The meeting
was chaired by IH. IH wrote the first draft of the manuscript. MC was
involved in critical review and editing of the original manuscript, and revised
versions thereof, in response to comments received from the acknowledged
contributors. Both authors read and approved the final manuscript.
Acknowledgements
This article builds on some of the concepts described in BioMed Central’s
draft open data statement, and as such a small number of passages from it
have been included verbatim in this article.
Thanks to Daniel Mietchen and Cameron Neylon for contributing practical
examples of open data in life sciences for this paper.
For their comments on an earlier draft of this paper, thanks to: Victoria
Stodden (Columbia University), Diane Cabell (Oxford Internet Institute), Ruth
Wilson (Nature Publishing Group), Daniel Mietchen (EvoMRI
Communications), Cameron Neylon (Public Library of Science, PLoS), Heather
Piwowar (University of British Columbia), Susanna Sansone (University of
Oxford), John Wilbanks (Ewing Marion Kauffman Foundation).
Hrynaszkiewicz and Cockerill BMC Research Notes 2012, 5:494 Page 11 of 12
http://www.biomedcentral.com/1756-0500/5/494Received: 11 June 2012 Accepted: 4 September 2012
Published: 7 September 2012
References
1. Fry J, Lockyer S, Oppenheim C, Houghton J, Rasmussen B: Identifying
benefits arising from the curation and open sharing of research data
produced by UK Higher Education and research institutes. 2009, 1–89.
[http://hdl.handle.net/2134/4600].
2. Wood J: Riding the wave: How Europe can gain from the rising tide of
scientific data. [http://cordis.europa.eu/fp7/ict/e-infrastructure/docs/hlg-sdi-
report.pdf]. Accessed 11th June 2012.
3. Walport M, Brest P: Sharing research data to improve public health.
Lancet 2011, 377:537–539.
4. Open Knowledge Definition - Defining the Open in Open Data, Open
Content and Open Information [http://opendefinition.org/okd/]. Accessed
11th June 2012.
5. Hrynaszkiewicz I: BioMed Central’s position statement on open data.
[http://blogs.openaccesscentral.com/blogs/bmcblog/resource/
opendatastatementdraft.pdf]. Accessed 11th June 2012.
6. Panton Principles [http://pantonprinciples.org/]. Accessed 11th June 2012.
7. Hargreaves I: Digital Opportunity: A Review of Intellectual Property and
Growth. [http://www.ipo.gov.uk/ipreview-finalreport.pdf]. Accessed 11th
June 2012.
8. McDonald D, Kelly U: The Value and Benefits of Text Mining. [http://www.
jisc.ac.uk/media/documents/publications/reports/2012/value-text-mining.
pdf]. Accessed 11th June 2012.
9. Schofield PN, Bubela T, Weaver T, Portilla L, Brown SD, Hancock JM, Einhorn D,
Tocchini-Valentini G, Hrabe AM, Rosenthal N: Post-publication sharing of data
and tools. Nature 2009, 461:171.
10. Conway PH, VanLare JM: Improving access to health care data: the open
government strategy. JAMA 2010, 304:1007–1008.
11. Contreras J: Prepublication data release, latency, and genome commons.
Science 2010, 329:393–394.
12. Gøtzsche PC: Why we need easy access to all data from all clinical trials
and how to accomplish it. Trials 2011, 12:249.
13. BioMed Central Blog: Report from the Publishing Open Data Working
Group meeting, 17th June 2011. [http://blogs.openaccesscentral.com/
blogs/bmcblog/entry/report_from_the_publishing_open]. Accessed 11th
June 2012.
14. Budapest Open Access Initiative [http://www.soros.org/openaccess/read].
Accessed 11th June 2012.
15. Carroll MW: Why full open access matters. PLoS Biol 2011, 9:e1001210.
16. Lyubomir P, Daniel M, Vishwas C, Gregor H, David R, Vincent S, David S:
Data Publishing Policies and Guidelines for Biodiversity Data.
[http://www.pensoft.net/J_FILES/Pensoft_Data_Publishing_Policies_and_
Guidelines.pdf]. Accessed 11th June 2012.
17. Using BioMed Central’s open access full-text corpus for text mining
research [http://www.biomedcentral.com/about/datamining]. Accessed 11th
June 2012.
18. STM, ALPSP: Databases, data sets, and data accessibility – views and
practices of scholarly publishers. [http://www.stm-assoc.org/
2006_06_01_STM_ ALPSP_Data_Statement.pdf]. Accessed 11th June 2012.
19. Swan A, Brown S: To Share or not to Share: Publication and Quality
Assurance of Research Data Outputs. [http://eprints.soton.ac.uk/266742/].
Accessed 11th June 2012.
20. Jones RH: Is there a property interest in scientific research data? High
Technology Law Journal 1987. [http://www.law.berkeley.edu/journals/btlj/
articles/vol1/jones.html]. Accessed 11th June 2012.
21. Guidelines - Ownership, copyright and intellectual property, Monash
University Research Data Management [http://www.researchdata.monash.
edu/guidelines/ownership.html]. Accessed 11th June 2012.
22. Guide to Open Data Licensing [http://opendefinition.org/guide/data/].
Accessed 11th June 2012.
23. Ball C: How to License Research Data | Digital Curation Centre. [http://
www.dcc.ac.uk/resources/how-guides/license-research-data]. Accessed 11th
June 2012.
24. Conformant Licenses. [http://opendefinition.org/licenses/]. Accessed 11th
June 2012.
25. Dalgleish R, Molero E, Kidd R, Jansen M, Past D, Robl A, Mons B, Diaz C,
Mons A, Brookes AJ: Solving bottlenecks in data sharing in the life
sciences. Hum Mutat 2012, doi:10.1002/humu.22123.26. CC0 use for data - CC Wiki [http://wiki.creativecommons.org/
CC0_use_for_data]. Accessed 11th June 2012.
27. Butler D: GlaxoSmithKline goes public with malaria data. Nature 2010,
doi:10.1038/news.2010.20.
28. Cologne-based libraries release 5.4 million bibliographic records via
CC0 - Creative Commons [http://creativecommons.org/weblog/entry/21344].
Accessed 11th June 2012.
29. Schaeffer P: Why does Dryad use CC0? [http://blog.datadryad.org/2011/10/
05/why-does-dryad-use-cc0/]. Accessed 11th June 2012.
30. Science Commons: Protocol for Implementing Open Access Data. [http://
sciencecommons.org/projects/publishing/open-access-data-protocol/].
Accessed 11th June 2012.
31. Hrynaszkiewicz I: LabArchives and BioMed Central: a new platform for
publishing scientific data. [http://blogs.openaccesscentral.com/blogs/
bmcblog/entry/labarchives_and_biomed_central_a]. Accessed 11th June
2012.
32. Wilbanks J: Attribution v. Citation. [http://scienceblogs.com/
commonknowledge/2009/06/attribution_v_citation.php]. Accessed 11th June
2012.
33. Rees J: Recommendations for independent scholarly publication of data
sets. [http://neurocommons.org/report/data-publication.pdf]. Accessed 11th
June 2012.
34. Piwowar HA, Day RS, Fridsma DB: Sharing detailed research data is
associated with increased citation rate. PLoS ONE 2007, 2(3):e308.
35. Ioannidis JPA, Allison DB, Ball CA, Coulibaly I, Cui X, Culhane AC, Falchi M,
Furlanello C, Game L, Jurman G, Mangion J, Mehta T, Nitzberg M, Page GP,
Petretto E, Noort VV: Repeatability of published microarray gene
expression analyses. Nat Genet 2009, 41:149–155.
36. Pienta AM, Alter GC, Lyle JA: The Enduring Value of Social Science
Research: The Use and Reuse of Primary Research Data. [http://deepblue.
lib.umich.edu/bitstream/2027.42/78307/1/pienta_alter_lyle_100331.pdf].
Accessed 11th June 2012.
37. Hrynaszkiewicz I: Citing and linking data to publications: more journals,
more examples. . .more impact? [http://blogs.openaccesscentral.com/
blogs/bmcblog/entry/citing_and_linking_data_to]. Accessed 11th June 2012.
38. Hrynaszkiewicz I: The need and drive for open data in biomedical
publishing. Serials 2011, 24:31–37.
39. Tapscott D, Williams AD: Wikinomics: How mass collaboration changes
everything. Portfolio; 2008.
40. Derry JM, Mangravite LM, Suver C, Furia M, Henderson D, Schildwachter X,
Izant J, Sieberts SK, Kellen MR, Friend SH: Developing predictive molecular
maps of human disease through community-based modeling. Nature
Precedings 2011, doi:10.1038/npre.2011.5883.1.
41. Errami M, Garner H: A tale of two citations. Nature 2008, 451:397–399.
42. Panton Principles: FAQ. [http://pantonprinciples.org/faq/]. Accessed 11th
June 2012.
43. Vickers A: Whose data set is it anyway? Sharing raw data from
randomized trials. Trials 2006, 7:15.
44. Sandercock PAG, Niewada M, Członkowska A: The International stroke trial
database. Trials 2011, 12:101.
45. Wikipedia definition of “Data” [http://en.wikipedia.org/w/index.php?
title=Data&oldid=506274317]. Accessed 11th June 2012.
46. Roberts D, Moritz T: A framework for publishing primary biodiversity data.
BMC Bioinformatics 2011, 12:11.
47. Wallis R: Linked Open Data and Pavlova. [http://blogs.talis.com/nodalities/
2010/08/the-linked-open-data-and-pavlova.php]. Accessed 11th June 2012.
48. Extensible Markup Language (XML) 1.0 (Fifth Edition) [http://www.w3.
org/TR/REC-xml/]. Accessed 11th June 2012.
49. Jones R, Macgillivray M, Murray-Rust P, Pitman J, Sefton P, O’Steen B, Waites W:
Open bibliography for science, technology, and medicine. Journal of
Cheminformatics 2011, 3:47.
50. Berners-Lee T: Linked Data. [http://www.w3.org/DesignIssues/LinkedData.
html]. Accessed 11th June 2012.
51. Willighagen EL, Brändle MP: Resource description framework technologies
in chemistry. Journal of Cheminformatics 2011, 3:15.
52. Open Source Licenses | Open Source Initiative [http://www.opensource.
org/licenses/index.html]. Accessed 11th June 2012.
53. Hrynaszkiewicz I, Cockerill M: In defence of supplemental data files: don’t
throw the baby out with the bathwater. [http://blogs.openaccesscentral.
com/blogs/bmcblog/entry/in_defence_of_supplemental_data]. Accessed
11th June 2012.
Hrynaszkiewicz and Cockerill BMC Research Notes 2012, 5:494 Page 12 of 12
http://www.biomedcentral.com/1756-0500/5/49454. 4.0/Draft 1 - CC Wiki [http://wiki.creativecommons.org/4.0/Draft_1].
Accessed 11th June 2012.
55. Thaney K: Sharing Data on the Web. [http://blogs.talis.com/nodalities/2010/
02/sharing-data-on-the-web.php]. Accessed 11th June 2012.
56. BioMed Central copyright and license agreement: [http://www.
biomedcentral.com/about/license]. Accessed 11th June 2012.
57. Mietchen D, Gaser C: Computational morphometry for detecting changes
in brain structure due to development, aging, learning, disease and
evolution. Frontiers in Neuroinformatics 2009, 3:25.
58. Wikipedia definition of “Small angle scattering” [http://en.wikipedia.org/
w/index.php?title=Small-angle_scattering&oldid=506086467]. Accessed 11th
June 2012.
59. Fenner M: Google Scholar Citations, Researcher Profiles, and why we
need an Open Bibliography. [http://blogs.plos.org/mfenner/2011/07/27/
google-scholar-citations-researcher-profiles-and-why-we-need-an-open-
bibliography/]. Accessed 11th June 2012.
60. Nyman T, Vikberg V, Smith DR, Boevé J-L: How common is ecological
speciation in plant-feeding insects? a “higher” nematinae perspective.
BMC Evol Biol 2010, 10:266.
doi:10.1186/1756-0500-5-494
Cite this article as: Hrynaszkiewicz and Cockerill: Open by default: a
proposed copyright license and waiver agreement for open access
research and data in peer-reviewed journals. BMC Research Notes 2012
5:494.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
